Dupont Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Dupont Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-31,874	Closed	-$279K	–	1252
2018 Q4	$279K	Hold	31,874	–	–	0.01%	953
2018 Q3	$535K	Hold	31,874	–	–	0.01%	700
2018 Q2	$668K	Hold	31,874	–	–	0.02%	647
2018 Q1	$513K	Buy	+31,874	New	+$631K	0.01%	671
2014 Q4	–	Sell	-39,651	Closed	-$323K	–	658
2014 Q3	$323K	Buy	+39,651	New	+$310K	0.01%	601

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dupont Capital Management's SPPI Position: Q1 2019 in Review

Dupont Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2019, closing a stake of 31,874 shares — an estimated $279K sold.

Dupont Capital Management first reported a position in SPPI in Q3 2014 and held it in 5 quarters. The position peaked at $668K in Q2 2018. 173 funds tracked by Wall St. Rank hold SPPI as of Q1 2019.

Dupont Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
Dupont Capital Management sold 31,874 Spectrum Pharmaceuticals Inc shares in Q1 2019, an estimated $279K.
Dupont Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2014 and held it in 5 quarters.
Dupont Capital Management's Spectrum Pharmaceuticals Inc position peaked at $668K in Q2 2018.
173 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2019.

Based on Dupont Capital Management's 13F filing for Q1 2019, filed 30 Apr 2019.